Detalles de la búsqueda
1.
Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination.
Cancer Immunol Immunother
; 72(1): 183-191, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35779095
2.
Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer.
Gynecol Oncol
; 164(1): 12-17, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34763937
3.
A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer.
Gynecol Oncol
; 157(1): 214-221, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31959492
4.
A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG study.
Gynecol Oncol
; 155(3): 393-399, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31653510
5.
A Randomized Trial of Prophylactic Extended Carboplatin Infusion to Reduce Hypersensitivity Reactions in Recurrent Ovarian Cancer.
Int J Gynecol Cancer
; 28(6): 1176-1182, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29757876
6.
Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer.
Cancer Discov
; 14(1): 49-65, 2024 01 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37849038
7.
Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission.
Cancers (Basel)
; 15(5)2023 Feb 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36900251
8.
Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer.
Gynecol Oncol
; 125(3): 621-4, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22446622
9.
Early postoperative CT as a prognostic biomarker in patients with advanced ovarian, tubal, and primary peritoneal cancer deemed optimally debulked at primary cytoreductive surgery.
AJR Am J Roentgenol
; 198(6): 1453-9, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22623562
10.
Small cell neuroendocrine carcinoma of the cervix: Analysis of prognostic factors and patterns of metastasis.
Gynecol Oncol Rep
; 43: 101058, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35967833
11.
OncoTree: A Cancer Classification System for Precision Oncology.
JCO Clin Cancer Inform
; 5: 221-230, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33625877
12.
The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatment.
Gynecol Oncol
; 116(3): 326-31, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19944454
13.
Incidence and management of bevacizumab-associated gastrointestinal perforations in patients with recurrent ovarian carcinoma.
Gynecol Oncol
; 116(3): 335-9, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20004956
14.
Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancer.
Gynecol Oncol
; 115(2): 209-14, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19664812
15.
Incidence of intestinal obstruction following intraperitoneal chemotherapy for ovarian tubal and peritoneal malignancies.
Gynecol Oncol
; 113(2): 228-32, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19254808
16.
A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer.
Gynecol Oncol
; 110(2): 140-5, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18554700
17.
Platinum resistance and impaired survival in patients with advanced primary peritoneal carcinoma: matched-case comparison with patients with epithelial ovarian carcinoma.
Am J Obstet Gynecol
; 198(2): 213.e1-7, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18226627
18.
Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer.
Clin Cancer Res
; 13(14): 4170-7, 2007 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17634545
19.
Translating inspiration from COVID-19 vaccine trials to innovations in clinical cancer research.
Cancer Cell
; 39(7): 897-899, 2021 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34004186
20.
A Phase I Study of Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission.
Cancers (Basel)
; 8(4)2016 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27110823